Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Cryogenic Tanks Market

ID: MRFR/Equip/46588-HCR
111 Pages
Chitranshi Jaiswal
Last Updated: April 06, 2026

China Cryogenic Tanks Market Research Report: By Cryogenic Liquid (Liquid Nitrogen, Liquefied Natural Gas (LNG), Liquid Hydrogen, Liquid Oxygen, Others), By Raw Material (Steel, Nickel Alloy, Aluminum Alloy), By Application (Storage, Transportation) andBy End-use Industry (Metal Processing, Energy Generation, Electronics, Medical Technology, Food & Beverage, Water Treatment, Others)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Cryogenic Tanks Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Application (USD Billion)
  49.     4.1.1 Liquid Nitrogen
  50.     4.1.2 Liquid Oxygen
  51.     4.1.3 Liquid Argon
  52.     4.1.4 Liquid Hydrogen
  53.     4.1.5 Liquid Helium
  54.   4.2 Pharmaceutical, BY End Use (USD Billion)
  55.     4.2.1 Healthcare
  56.     4.2.2 Aerospace
  57.     4.2.3 Energy
  58.     4.2.4 Food and Beverage
  59.     4.2.5 Electronics
  60.   4.3 Pharmaceutical, BY Material Type (USD Billion)
  61.     4.3.1 Stainless Steel
  62.     4.3.2 Carbon Steel
  63.     4.3.3 Aluminum
  64.     4.3.4 Composite Materials
  65.     4.3.5 Glass-Lined Steel
  66.   4.4 Pharmaceutical, BY Tank Type (USD Billion)
  67.     4.4.1 Vertical Tanks
  68.     4.4.2 Horizontal Tanks
  69.     4.4.3 Mobile Tanks
  70.     4.4.4 Stationary Tanks
  71.     4.4.5 Cryogenic Storage Tanks
  72. 5 SECTION V: COMPETITIVE ANALYSIS
  73.   5.1 Competitive Landscape
  74.     5.1.1 Overview
  75.     5.1.2 Competitive Analysis
  76.     5.1.3 Market share Analysis
  77.     5.1.4 Major Growth Strategy in the Pharmaceutical
  78.     5.1.5 Competitive Benchmarking
  79.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  80.     5.1.7 Key developments and growth strategies
  81.       5.1.7.1 New Product Launch/Service Deployment
  82.       5.1.7.2 Merger & Acquisitions
  83.       5.1.7.3 Joint Ventures
  84.     5.1.8 Major Players Financial Matrix
  85.       5.1.8.1 Sales and Operating Income
  86.       5.1.8.2 Major Players R&D Expenditure. 2023
  87.   5.2 Company Profiles
  88.     5.2.1 Linde (DE)
  89.       5.2.1.1 Financial Overview
  90.       5.2.1.2 Products Offered
  91.       5.2.1.3 Key Developments
  92.       5.2.1.4 SWOT Analysis
  93.       5.2.1.5 Key Strategies
  94.     5.2.2 Air Products (US)
  95.       5.2.2.1 Financial Overview
  96.       5.2.2.2 Products Offered
  97.       5.2.2.3 Key Developments
  98.       5.2.2.4 SWOT Analysis
  99.       5.2.2.5 Key Strategies
  100.     5.2.3 Cryogenmash (RU)
  101.       5.2.3.1 Financial Overview
  102.       5.2.3.2 Products Offered
  103.       5.2.3.3 Key Developments
  104.       5.2.3.4 SWOT Analysis
  105.       5.2.3.5 Key Strategies
  106.     5.2.4 Wessington Cryogenics (GB)
  107.       5.2.4.1 Financial Overview
  108.       5.2.4.2 Products Offered
  109.       5.2.4.3 Key Developments
  110.       5.2.4.4 SWOT Analysis
  111.       5.2.4.5 Key Strategies
  112.     5.2.5 Chart Industries (US)
  113.       5.2.5.1 Financial Overview
  114.       5.2.5.2 Products Offered
  115.       5.2.5.3 Key Developments
  116.       5.2.5.4 SWOT Analysis
  117.       5.2.5.5 Key Strategies
  118.     5.2.6 Baowu Steel Group (CN)
  119.       5.2.6.1 Financial Overview
  120.       5.2.6.2 Products Offered
  121.       5.2.6.3 Key Developments
  122.       5.2.6.4 SWOT Analysis
  123.       5.2.6.5 Key Strategies
  124.     5.2.7 Huanghe Hydropower (CN)
  125.       5.2.7.1 Financial Overview
  126.       5.2.7.2 Products Offered
  127.       5.2.7.3 Key Developments
  128.       5.2.7.4 SWOT Analysis
  129.       5.2.7.5 Key Strategies
  130.     5.2.8 Sichuan Air Separation (CN)
  131.       5.2.8.1 Financial Overview
  132.       5.2.8.2 Products Offered
  133.       5.2.8.3 Key Developments
  134.       5.2.8.4 SWOT Analysis
  135.       5.2.8.5 Key Strategies
  136.   5.3 Appendix
  137.     5.3.1 References
  138.     5.3.2 Related Reports
  139. 6 LIST OF FIGURES
  140.   6.1 MARKET SYNOPSIS
  141.   6.2 CHINA MARKET ANALYSIS BY APPLICATION
  142.   6.3 CHINA MARKET ANALYSIS BY END USE
  143.   6.4 CHINA MARKET ANALYSIS BY MATERIAL TYPE
  144.   6.5 CHINA MARKET ANALYSIS BY TANK TYPE
  145.   6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
  146.   6.7 RESEARCH PROCESS OF MRFR
  147.   6.8 DRO ANALYSIS OF PHARMACEUTICAL
  148.   6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  149.   6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  150.   6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  151.   6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
  152.   6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion)
  153.   6.14 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
  154.   6.15 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Billion)
  155.   6.16 PHARMACEUTICAL, BY MATERIAL TYPE, 2024 (% SHARE)
  156.   6.17 PHARMACEUTICAL, BY MATERIAL TYPE, 2024 TO 2035 (USD Billion)
  157.   6.18 PHARMACEUTICAL, BY TANK TYPE, 2024 (% SHARE)
  158.   6.19 PHARMACEUTICAL, BY TANK TYPE, 2024 TO 2035 (USD Billion)
  159.   6.20 BENCHMARKING OF MAJOR COMPETITORS
  160. 7 LIST OF TABLES
  161.   7.1 LIST OF ASSUMPTIONS
  162.     7.1.1
  163.   7.2 China MARKET SIZE ESTIMATES; FORECAST
  164.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  165.     7.2.2 BY END USE, 2026-2035 (USD Billion)
  166.     7.2.3 BY MATERIAL TYPE, 2026-2035 (USD Billion)
  167.     7.2.4 BY TANK TYPE, 2026-2035 (USD Billion)
  168.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  169.     7.3.1
  170.   7.4 ACQUISITION/PARTNERSHIP
  171.     7.4.1

China Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Billion, 2026-2035)

  • Liquid Nitrogen
  • Liquid Oxygen
  • Liquid Argon
  • Liquid Hydrogen
  • Liquid Helium

Pharmaceutical By End Use (USD Billion, 2026-2035)

  • Healthcare
  • Aerospace
  • Energy
  • Food and Beverage
  • Electronics

Pharmaceutical By Material Type (USD Billion, 2026-2035)

  • Stainless Steel
  • Carbon Steel
  • Aluminum
  • Composite Materials
  • Glass-Lined Steel

Pharmaceutical By Tank Type (USD Billion, 2026-2035)

  • Vertical Tanks
  • Horizontal Tanks
  • Mobile Tanks
  • Stationary Tanks
  • Cryogenic Storage Tanks

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions